FindTrial
Sign In

Asia Pacific Neuro-Endocrine Tumor Registry

An observational Registry in the Asia Pacific region collecting longitudinal data on the management of Neuro-Endocrine Tumor patients in routine practice - NET

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2010/091/001039
Enrollment
200
Registered
2010-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Neuro-Endocrine Tumor

Interventions

Intervention1: Nil: Nil Control Intervention1: Nill: Nill

Sponsors

World congress HPB TERF Alka th Road SantacruzWest Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or female patient aged 18-80 years 2. Patient with histopathologically confirmed NET (functional and non functional) 3. Patient newly diagnosed or under treatment for the last 3 yrs

Exclusion criteria

Exclusion criteria: 1. Female patients who are pregnant or lactating, or are of childbirth potential and not practicing a medically acceptable method for birth control.

Design outcomes

Primary

MeasureTime frame
To assess the current practice and management of NET patientsTimepoint: Observational Registry—

Secondary

MeasureTime frame
To use this database to optimize early diagnosis and treatment of NET.Timepoint: Observational Registry—

Countries

India

Contacts

Public ContactDr P Jagannath

Lilavati Hospital

drjagannath@gmail.com02266529999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026